Showering two to three times a week is normally enough. But if you have skin conditions like atopic dermatitis, commonly known as eczema, you will have to take extra measures. This poses the ...

Far from doffing their caps to actinic keratosis (AK), dermatology drug developers Almirall and Biofrontera are keeping things firmly covered to raise awareness of the skin cancer precursor.

Atopic dermatitis is a chronic (long-lasting) skin condition that causes dry, itchy patches of skin that may crack or ooze. It is the most common form of eczema. Itchiness occurs when an ...

including the holistic and personalized treatment of atopic dermatitis and psoriasis. The comprehensive program covers a broad range of skin diseases such as actinic keratosis, androgenetic ...

The conference focuses on the latest advancements in medical dermatology, including the holistic and personalized treatment of atopic dermatitis and psoriasis. The comprehensive program covers a broad ...

A medical research team has confirmed that ultrafine bubble showers significantly suppress inflammation in mice with atopic dermatitis due to external factors. Bubble baths might be soothing soaks ...

New data analysis on Tirbanibulin shows consistent treatment response for actinic keratosis (AK): data from phase ... particularly its focus on advanced biologic solutions for psoriasis and atopic ...

New data analysis on Tirbanibulin shows consistent treatment response for actinic keratosis (AK ... biologic solutions for psoriasis and atopic dermatitis, underscores its dedication to improving ...

Getty Images Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of presentation ...

Dry skin and atopic dermatitis risk in winter: Many people deal with skin issues in the winter season, when there is little humidity and more dryness in the air. Long term exposure to cold air can ...

At the congress, Almirall will present 34 abstracts detailing the latest research on lebrikizumab for moderate-to-severe atopic dermatitis ... as tirbanibulin for actinic keratosis.

At the congress, Almirall will present 34 abstracts detailing the latest research on lebrikizumab for moderate-to-severe atopic dermatitis in adolescents ... as well as tirbanibulin for actinic ...